Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)
CUSIP: 22978P106
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 43,411,663
- Total 13F shares
- 11,402,706
- Share change
- -356,649
- Total reported value
- $10,374,424
- Put/Call ratio
- 14%
- Price per share
- $0.91
- Number of holders
- 49
- Value change
- -$452,161
- Number of buys
- 15
- Number of sells
- 25
Quarterly Holders Quick Answers
What is CUSIP 22978P106?
CUSIP 22978P106 identifies CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 22978P106:
Top shareholders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bleichroeder LP |
13F
13D/G
|
Company |
10%
from 13D/G
|
4,997,240
|
$5,446,992 | — | 31 Dec 2024 | |
| Michael J. Fox |
3/4/5
|
Director |
—
mixed-class rows
|
1,148,800
mixed-class rows
|
$3,036,000 | — | 05 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.7%
|
2,056,176
|
$2,241,232 | — | 31 Dec 2024 | |
| Cameron Gray |
3/4/5
|
Director |
—
class O/S missing
|
687,049
|
$1,896,255 | — | 14 Jun 2022 | |
| Mark E. Strome |
13D/G
|
— |
5%
|
2,166,242
|
$1,862,968 | $0 | 14 Nov 2022 | |
| Slate Path Capital LP |
13D/G
|
— |
1.4%
|
918,836
|
$790,199 | $0 | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
1.5%
|
638,952
|
$696,458 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
631,281
|
$688,251 | — | 31 Dec 2024 | |
| Robertson Stephens Wealth Management, LLC |
13F
|
Company |
1.1%
|
478,500
|
$521,565 | — | 31 Dec 2024 | |
| Sigma Planning Corp |
13F
|
Company |
1%
|
447,175
|
$487,421 | — | 31 Dec 2024 | |
| Good Life Advisors, LLC |
13F
|
Company |
0.92%
|
400,000
|
$436,000 | — | 31 Dec 2024 | |
| Anish Suri |
3/4/5
|
PRESIDENT AND CSO |
—
mixed-class rows
|
285,638
mixed-class rows
|
$374,361 | — | 05 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.75%
|
324,315
|
$353,503 | — | 31 Dec 2024 | |
| ADVISORY RESEARCH INC |
13F
|
Company |
0.59%
|
257,225
|
$280,375 | — | 31 Dec 2024 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.49%
|
211,361
|
$230,383 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.48%
|
208,206
|
$226,944 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.44%
|
189,753
|
$206,831 | — | 31 Dec 2024 | |
| Daniel R. Passeri |
3/4/5
|
CHIEF EXECUTIVE OFFICER, Director |
—
mixed-class rows
|
614,578
mixed-class rows
|
$169,515 | — | 21 Mar 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.35%
|
149,798
|
$163,000 | — | 31 Dec 2024 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.3%
|
128,284
|
$139,830 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.16%
|
69,295
|
$75,532 | — | 31 Dec 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.15%
|
63,767
|
$69,506 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.13%
|
58,314
|
$63,562 | — | 31 Dec 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.11%
|
49,055
|
$53,000 | — | 31 Dec 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.11%
|
46,973
|
$51,201 | — | 31 Dec 2024 | |
| LPL Financial LLC |
13F
|
Company |
0.1%
|
42,929
|
$46,793 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.08%
|
34,525
|
$37,632 | — | 31 Dec 2024 | |
| Texas Capital Bank Wealth Management Services Inc |
13F
|
Company |
0.08%
|
33,102
|
$36,081 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
28,693
|
$31,276 | — | 31 Dec 2024 | |
| Point72 Asia (Singapore) Pte. Ltd. |
13F
|
Company |
0.06%
|
27,764
|
$30,263 | — | 31 Dec 2024 | |
| Navalign, LLC |
13F
|
Company |
0.06%
|
25,000
|
$27,250 | — | 31 Dec 2024 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.05%
|
20,000
|
$22,000 | — | 31 Dec 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.05%
|
20,077
|
$21,884 | — | 31 Dec 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.05%
|
19,680
|
$21,451 | — | 31 Dec 2024 | |
| Virtu Financial LLC |
13F
|
Company |
0.04%
|
16,829
|
$18,000 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.03%
|
13,258
|
$14,451 | — | 31 Dec 2024 | |
| SeaCrest Wealth Management, LLC |
13F
|
Company |
0.03%
|
13,000
|
$14,170 | — | 31 Dec 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
10,542
|
$11,491 | — | 31 Dec 2024 | |
| Beacon Pointe Advisors, LLC |
13F
|
Company |
0.02%
|
10,000
|
$10,900 | — | 31 Dec 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.02%
|
6,908
|
$7,000 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
6,029
|
$6,572 | — | 31 Dec 2024 | |
| Gleason Group, Inc. |
13F
|
Company |
0.01%
|
6,000
|
$6,540 | — | 31 Dec 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.01%
|
3,661
|
$3,990 | — | 31 Dec 2024 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0.01%
|
3,000
|
$3,270 | — | 31 Dec 2024 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0.01%
|
2,550
|
$2,780 | — | 31 Dec 2024 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.01%
|
2,500
|
$2,725 | — | 31 Dec 2024 | |
| Golden State Wealth Management, LLC |
13F
|
Company |
0%
|
2,000
|
$2,180 | — | 31 Dec 2024 | |
| Larson Financial Group LLC |
13F
|
Company |
0%
|
1,400
|
$1,526 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,062
|
$1,157 | — | 31 Dec 2024 | |
| Physician Wealth Advisors, Inc. |
13F
|
Company |
0%
|
1,006
|
$1,097 | — | 31 Dec 2024 |
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q1 2025
As of 31 Mar 2025,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,402,706 shares.
The largest 10 holders included
Bleichroeder LP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., Robertson Stephens Wealth Management, LLC, Sigma Planning Corp, BANK OF AMERICA CORP /DE/, ADVISORY RESEARCH INC, STIFEL FINANCIAL CORP, and NORTHERN TRUST CORP.
This page lists
49
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
55
Q1 2025 holders
49
Holder diff
-6
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.